Schobel Alexander Mark's Form 4 filing
Aquestive Therapeutics, Inc. (AQST) · filed Jun 10, 2022
- Accession no.
- 0001628280-22-016875
- Filed
- Jun 10, 2022, 5:26 PM ET
- Trade date
- Jun 8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $44.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schobel Alexander MarkCIK 0001406836 | Officer (Chief Innovation/Tech Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | Common Stock | PPurchaseAcquired | +45,871 | $0.96 | +$44,036.16 | 882,871 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | Common Stock | PPurchaseAcquired | +45,871 | $0.13 | +$5,963.23 | 45,871 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.